Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOS vs GnRH Antagonist Protocol in PCOS Women Undergoing PGT-A
NCT05326087Phase 3Not yet recruiting
- Sponsor
- Shanghai Ji Ai Genetics & IVF Institute
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of medroxyprogesterone acetate in polycystic ovary syndrome (PCOS), sponsored by Shanghai Ji Ai Genetics & IVF Institute. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
medroxyprogesterone acetate
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05326087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05326087.